![simon medical imaging simon medical imaging](http://s3-media1.fl.yelpcdn.com/bphoto/A6BMSufVDfNLmD1cCwMtyQ/l.jpg)
Myocarditis and pericarditis are both inflammatory conditions of the heart. the long-term consequences of this condition secondary to vaccination are yet unknown, so any screening recommendations need to be balanced against the frequency and severity of the disease with the aim to prevent complications, in particular of myocarditis (arrhythmias, long term myocardial damage or heart failure).the majority of cases appear to be mild and self-limiting any acutely ill or unstable patients should be referred to hospital directly.diagnosis of myocarditis and pericarditis should follow published international guidelines.no long-term follow-up data is available yet on hospitalised patients.In 2 studies from the US, significant left ventricular ( LV) fibrosis has been described in a high percentage of those children admitted to hospital, with a small percentage of these having non-sustained ventricular tachycardia ( VT) Myocarditis – a very small number of those with this condition have been admitted to hospital. myocarditis and pericarditis following vaccination is usually mild or stable and most patients typically recover fully without medical treatment.most patients who develop symptoms have usually been vaccinated with a mRNA vaccine (Pfizer or Moderna).most patients who develop symptoms do so within a week of vaccination.this is a rare condition following vaccination (see the Medicines and Healthcare products Regulatory Agency’s ( MHRA) weekly summary for the latest data).It is a living document and will be reviewed and updated as further data becomes available.īackground to myocarditis and pericarditis after COVID-19 vaccination and guidelines:
![simon medical imaging simon medical imaging](https://pbs.twimg.com/media/DlzJhuVU8AA1Qye.jpg)
The UK Health Security Agency ( UKHSA), in partnership with the Royal College of General Practitioners ( RCGP) and the Royal College of Emergency Medicine ( RCEM), has produced this clinical guidance to support the detection and management of clinical cases of myocarditis and pericarditis associated with coronavirus ( COVID-19) vaccination.